Deutsche Bank AG Takes Position in Astera Labs, Inc. $ALAB

Deutsche Bank AG acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 674,096 shares of the company’s stock, valued at approximately $325,602,000. Deutsche Bank AG owned approximately 0.39% of Astera Labs at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Atreides Management LP raised its holdings in shares of Astera Labs by 108.9% in the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after buying an additional 1,754,593 shares during the last quarter. Amundi raised its stake in shares of Astera Labs by 1,298.6% during the third quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after buying an additional 1,319,643 shares during the last quarter. Artisan Partners Limited Partnership bought a new stake in shares of Astera Labs during the 4th quarter valued at $148,980,000. Goldman Sachs Group Inc. lifted its stake in Astera Labs by 189.0% in the fourth quarter. Goldman Sachs Group Inc. now owns 1,312,927 shares of the company’s stock valued at $218,419,000 after buying an additional 858,693 shares during the period. Finally, State Street Corp raised its position in shares of Astera Labs by 32.5% in the 4th quarter. State Street Corp now owns 3,099,809 shares of the company’s stock valued at $515,684,000 after acquiring an additional 760,358 shares during the period. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Price Performance

Astera Labs stock opened at $320.17 on Tuesday. The stock’s 50 day moving average is $357.48 and its 200 day moving average is $241.79. Astera Labs, Inc. has a one year low of $97.89 and a one year high of $499.48. The firm has a market cap of $55.55 billion, a P/E ratio of 158.50 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping the consensus estimate of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. During the same period in the prior year, the company posted $0.44 earnings per share. Astera Labs’s revenue for the quarter was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities analysts anticipate that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.

Analyst Ratings Changes

ALAB has been the topic of a number of research analyst reports. Needham & Company LLC raised their price target on Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. Weiss Ratings raised shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, May 21st. Susquehanna upped their target price on Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a report on Friday, July 31st. Evercore reaffirmed an “outperform” rating and set a $297.00 price target on shares of Astera Labs in a research report on Tuesday, May 19th. Finally, Barclays raised their price objective on Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a research report on Monday, July 20th. One research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and eight have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $333.00.

Insider Activity at Astera Labs

In other news, Director Jack R. Lazar sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the completion of the sale, the director owned 75,688 shares of the company’s stock, valued at $26,882,106.96. This trade represents a 11.67% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the firm’s stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $311.83, for a total transaction of $1,092,964.15. Following the completion of the sale, the director owned 53,961 shares of the company’s stock, valued at $16,826,658.63. The trade was a 6.10% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 631,979 shares of company stock worth $215,479,247. Corporate insiders own 10.40% of the company’s stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.